Canton Strategic Holdings Inc
Market Cap
$156.14M
P/E Ratio
-1.07
EPS
$-3.68
Dividend Yield
0.00%
52-Week Range
$0.95 — $9.08
Volume
319.62K
Avg Volume
902.13K
Beta
1.44
P/E (TTM)
-1.07
Forward P/E
—
PEG Ratio
-0.08
P/S (TTM)
0.00
P/B (TTM)
4.54
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-5.88%
ROA (TTM)
-1.34%
ROIC
—
Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
—
Debt/Equity
0.03
Current Ratio
4.98
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.44%
EPS Growth (5Y)
-0.35%
Sales Growth (3Y)
+0.00%
Sales Growth (5Y)
+0.00%
EPS Est (This Year)
$-0.75
EPS Est (Next Year)
$-0.90
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$1.22
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
39.53M
Float
31.84M
Free Float %
80.54%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2024-03-28
Employees
2
CEO
Mark Wendland
Index Membership
—
Website
https://www.cantonstrategic.com
Canton Strategic Holdings Inc (CNTN) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $156.14M, a P/E ratio of -1.07, CNTN is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare CNTN against other stocks using dozens of fundamental and technical filters.
CYBN
Cybin Inc.
$8.28
+1.22%
$413.02M
FRX.TO
Fennec Pharmaceuticals Inc.
$10.72
-0.05%
$295.33M
OBI.L
Ondine Biomedical Inc.
$11.00
+0.00%
$47.11M
BTX
BlackRock Technology and Private Equity Term Trust
$6.49
+1.56%
$757.45M
LXEO
Lexeo Therapeutics, Inc. Common Stock
$6.38
-2.89%
$465.66M
ETON
Eton Pharmaceuticals, Inc.
$18.92
-0.47%
$507.39M
Canton Strategic Holdings Inc (CNTN) has a trailing twelve-month (TTM) P/E ratio of -1.07. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Canton Strategic Holdings Inc (CNTN) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Canton Strategic Holdings Inc (CNTN) has a market capitalization of $156.14 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.